Kurdistan Deputy Prime Minister to Asharq Al-Awsat: Targeting Erbil Airport is a Violation of Iraq's Sovereignty

Kurdistan Region of Iraq Deputy Prime Minister Qubad Talabani (Asharq Al-Awsat)
Kurdistan Region of Iraq Deputy Prime Minister Qubad Talabani (Asharq Al-Awsat)
TT

Kurdistan Deputy Prime Minister to Asharq Al-Awsat: Targeting Erbil Airport is a Violation of Iraq's Sovereignty

Kurdistan Region of Iraq Deputy Prime Minister Qubad Talabani (Asharq Al-Awsat)
Kurdistan Region of Iraq Deputy Prime Minister Qubad Talabani (Asharq Al-Awsat)

The Deputy Prime Minister of Iraq’s Kurdistan Region, Qubad Talabani, described targeting Erbil International Airport and diplomatic missions as a "terrorist act that serves the narrow agendas and interests of the parties behind them."

In an interview with Asharq Al-Awsat, Talabani stressed the need to coordinate efforts to stop these attacks that "violate Iraq's sovereignty."

A drone has attacked Erbil International Airport in northern Iraq with explosives, which caused fires in the vicinity of the US military base inside the airport without causing casualties.

Talabani noted that the parties behind these attacks are only interested in their narrow interests and agendas.

He stressed “the importance of coordinating efforts between the security services in Baghdad and Kurdistan" and intensifying cooperation and support from the international community to counter these attacks, which are a violation of the state's laws.

According to Talabani, if these attacks continue, they would create a state of chaos in the country and threaten the state's sovereignty, which will negatively affect the interests of Iraq and its relationship with the international community.

Former MP Majid Shankali warned that armed and pro-Iranian factions destabilize the region through continuous attacks on Erbil and foreign interests.

"It is a message to the US troops that their presence is unwelcomed in Iraq and that these factions are capable of targeting them anywhere in the country," he said.

Shankali told Asharq Al-Awsat that the Iraqi government, which has agreements with the US, must put an end to such attacks or allow the Peshmerga forces to deploy in the areas used by these factions.

The armed factions loyal to Iran are a parallel force for the Iraqi state and work according to their agendas using state funds, announced Shankali.

Writer and journalist Omar Abdul Qader described the attacks as a systematic and dangerous escalation by the pro-Iran factions against the US presence in Iraq.

He told Asharq Al-Awsat that these attacks serve the agendas of foreign parties, stressing that the Iraqi government should take serious steps to stop these attacks.

Abdul Qader warned that they would have political, economic, and security consequences on the already deteriorating political and security conditions and make it difficult for the government to hold early elections next October.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.